News

Filter

Current filters:

Mergers & Acquisitions

1 to 9 of 1544 results

GSK and Novartis complete major three-part transaction

02-03-2015

UK pharma major GlaxoSmithKline said this morning that its three-part transaction with Swiss peer Novartis…

GlaxoSmithKlineMergers & AcquisitionsNovartisOncologyPharmaceuticalVaccines

AstraZeneca to spin-out early-stage antibiotic R&D into stand-alone company

AstraZeneca to spin-out early-stage antibiotic R&D into stand-alone company

28-02-2015

Anglo-Swedish pharma major AstraZeneca is changing the structure of its small-molecule early-stage anti-infectives…

Antibiotics and Infectious diseasesAstraZenecaMergers & AcquisitionsPharmaceuticalResearchUK

2015 outlook for US and EU pharma; report

2015 outlook for US and EU pharma; report

27-02-2015

According to this Global Pharma US & EU Outlook 2015 report, strategy diversification stays divested…

EuropeManagementMarkets & MarketingMergers & AcquisitionsPatentsPharmaceuticalUSA

Takeda acquires 13 products from Turkish company Neutec

Takeda acquires 13 products from Turkish company Neutec

25-02-2015

Takeda GmbH, the wholly-owned subsidiary of Japanese drugmaker Takeda has signed an agreement to obtain…

Markets & MarketingMergers & AcquisitionsPharmaceuticalTakeda PharmaceuticalTurkey

Shire acquires Meritage Pharma, strengthening rare diseases pipeline

Shire acquires Meritage Pharma, strengthening rare diseases pipeline

24-02-2015

In a second acquisition this year, Ireland-headquartered Shire revealed today that it has taken control…

BiotechnologyGastro-intestinalsMergers & AcquisitionsMeritage PharmaRare diseasesShire

Federal Trade Commission puts conditions on Novartis acquisition of GSK oncology portfolio

Federal Trade Commission puts conditions on Novartis acquisition of GSK oncology portfolio

24-02-2015

The US Federal Trade Commission has put conditions on the proposed acquisition by Novartis of GlaxoSmithKline’s…

Array BioPharmaGSKLegalMergers & AcquisitionsNovartisOncologyPharmaceuticalRegulationResearchUSA

Ipsen pays 6 million euros for option to acquire Canbex

24-02-2015

French drugmaker Ipsen today announced that UK-based biotech firm Canbex Therapeutics has granted an…

BiotechnologyCanbex TherapeuticsIpsenMergers & AcquisitionsNeurologicalVSN16R

Marathon Pharma sells non-strategic products to Valeant

24-02-2015

Marathon Pharmaceuticals, a privately held US biopharmaceuticals company focused on drugs for people…

Marathon PharmaceuticalsMergers & AcquisitionsPharmaceuticalRare diseasesValeant Pharmaceuticals International

1 to 9 of 1544 results

COMPANY SPOTLIGHT

Menarini

Back to top